Literature DB >> 9845001

Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory.

V Raghavendra1, K Chopra, S K Kulkarni.   

Abstract

In the present study we have shown the potential memory enhancing property of losartan, a selective Ang II AT1 receptor antagonist. Nootropic activity of losartan in mice was assessed by using passive avoidance step-down task and elevated plus-maze as a measure of short-term working and spatial memory respectively. Losartan at higher dose (10 mg/kg i.p) improved the basal performance in retention testing in both the test paradigms. Prior administration of losartan also attenuated retention deficit induced by scopolamine (0.3 mg/kg i.p). Moreover, physostigmine (0.05 mg/kg i.p) potentiated memory enhancing properties of losartan administered at lower dose (5 mg/kg i.p). On the basis of above observations it is concluded that the memory enhancing properties of losartan can be attributed to increased cholinergic activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9845001     DOI: 10.1016/s0143-4179(98)90065-8

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  13 in total

1.  Renin angiotensin system gene polymorphisms modify angiotensin-converting enzyme inhibitors' effect on cognitive function: the health, aging and body composition study.

Authors:  Ihab Hajjar; Stephen Kritchevsky; Anne B Newman; Rongling Li; Kristine Yaffe; Eleanor M Simonsick; Lewis A Lipsitz
Journal:  J Am Geriatr Soc       Date:  2010-06       Impact factor: 5.562

2.  Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function.

Authors:  Santoshkumar Tota; Kashif Hanif; Pradeep Kumar Kamat; Abul Kalam Najmi; Chandishwar Nath
Journal:  Psychopharmacology (Berl)       Date:  2012-02-24       Impact factor: 4.530

Review 3.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

Review 4.  Antihypertensive agents for aging patients who are at risk for cognitive dysfunction.

Authors:  Ihab Hajjar; Michelle Keown; Brandy Frost
Journal:  Curr Hypertens Rep       Date:  2005-12       Impact factor: 5.369

5.  Angiotensin II blocks memory consolidation through an AT2 receptor-dependent mechanism.

Authors:  Daniel S Kerr; Lia R M Bevilaqua; Juliana S Bonini; Janine I Rossato; Cristiano A Köhler; Jorge H Medina; Iván Izquierdo; Martín Cammarota
Journal:  Psychopharmacology (Berl)       Date:  2004-11-17       Impact factor: 4.530

Review 6.  Effect of antihypertensive agents on quality of life in the elderly.

Authors:  Roberto Fogari; Annalisa Zoppi
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

7.  Impaired spatial memory and altered dendritic spine morphology in angiotensin II type 2 receptor-deficient mice.

Authors:  Björn Maul; Oliver von Bohlen und Halbach; Axel Becker; Anja Sterner-Kock; Jörg-Peter Voigt; Wolf-Eberhard Siems; Gisela Grecksch; Thomas Walther
Journal:  J Mol Med (Berl)       Date:  2008-03-12       Impact factor: 4.599

Review 8.  The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?

Authors:  Patrick Gavin Kehoe
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

9.  Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis.

Authors:  Nien-Chen Li; Austin Lee; Rachel A Whitmer; Miia Kivipelto; Elizabeth Lawler; Lewis E Kazis; Benjamin Wolozin
Journal:  BMJ       Date:  2010-01-12

10.  Roles of Brain Angiotensin II in Cognitive Function and Dementia.

Authors:  Masaki Mogi; Jun Iwanami; Masatsugu Horiuchi
Journal:  Int J Hypertens       Date:  2012-12-11       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.